Literature DB >> 9893380

Filovirus diseases.

C J Peters1, A S Khan.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 9893380     DOI： 10.1007/978-3-642-59949-1_6

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  20 in total

1.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.

Authors:  Akihito Yonezawa; Marielle Cavrois; Warner C Greene
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 3.  Ebola virus pathogenesis: implications for vaccines and therapies.

Authors:  Nancy Sullivan; Zhi-Yong Yang; Gary J Nabel
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 4.  Ebola Vaccine: How Far are we?

Authors:  Rajani Sharma; Ketki Jangid
Journal:  J Clin Diagn Res       Date:  2017-05-01

5.  Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies.

Authors:  H Ito; S Watanabe; A Takada; Y Kawaoka
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Discovery and Structural Optimization of 4-(Aminomethyl)benzamides as Potent Entry Inhibitors of Ebola and Marburg Virus Infections.

Authors:  Irina N Gaisina; Norton P Peet; Letitia Wong; Adam M Schafer; Han Cheng; Manu Anantpadma; Robert A Davey; Gregory R J Thatcher; Lijun Rong
Journal:  J Med Chem       Date:  2020-06-17       Impact factor: 7.446

Review 7.  What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? The Importance of Bridging Studies and Species-Independent Correlates of Protection.

Authors:  Hana Golding; Surender Khurana; Marina Zaitseva
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

8.  Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola.

Authors:  Jonathan S Towner; Marina L Khristova; Tara K Sealy; Martin J Vincent; Bobbie R Erickson; Darcy A Bawiec; Amy L Hartman; James A Comer; Sherif R Zaki; Ute Ströher; Filomena Gomes da Silva; Fernando del Castillo; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

9.  Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Authors:  Michael Weik; Jens Modrof; Hans-Dieter Klenk; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Infectivity-enhancing antibodies to Ebola virus glycoprotein.

Authors:  A Takada; S Watanabe; K Okazaki; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.